| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/06/1995 | US5422110 Enhanced immunogenicity using leukotoxin chimeras |
| 06/06/1995 | US5422109 Fluid vaccines and active principle vehicles containing a metabolizable oil |
| 06/06/1995 | US5422103 Wound healing agents for burns, bed sores; blended with dextran |
| 06/06/1995 | US5422102 Diclofenac or salt with nonionic polymer of hydroxypropyl and/or hydroxyethyl cellulose; percutaneous adsorption |
| 06/06/1995 | US5422101 Cholesterol lowering drink mix compositions |
| 06/06/1995 | CA2044795C Dermatological composition based on an aqueous phase |
| 06/06/1995 | CA1335858C Polyanhydrides with improved hydrolytic degradation properties |
| 06/06/1995 | CA1335800C Synovial phospholipases |
| 06/06/1995 | CA1335788C Protein absorption enhancing agents |
| 06/01/1995 | WO1995014791A1 Design of drugs involving receptor-ligand-dna interactions |
| 06/01/1995 | WO1995014707A1 N-2 substituted purines |
| 06/01/1995 | WO1995014651A1 Amphiphilic derivatives of piperazine |
| 06/01/1995 | WO1995014531A1 Particles for binding monovalent cations, use of such particles as well as methods for scavenging and removing sodium and/or potassium ions |
| 06/01/1995 | WO1995014493A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | WO1995014484A1 In vivo free-radical generator |
| 06/01/1995 | WO1995014483A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
| 06/01/1995 | WO1995014480A1 Composition for curing lesioned tissue, process for producing the same, and use thereof |
| 06/01/1995 | WO1995014463A1 Composition of pharmaceutical preparation improved in peroral absorbability |
| 06/01/1995 | WO1995014460A1 Opioid formulations for treating pain |
| 06/01/1995 | WO1995014459A1 Liposomes for the encapsulation of doxorubicine |
| 06/01/1995 | WO1995014381A1 Amphiphilic derivatives of guanidine |
| 06/01/1995 | WO1995014380A1 Amphiphilic imidazolinium derivatives |
| 06/01/1995 | WO1995003315A3 Saccharides, their synthesis and use |
| 06/01/1995 | DE4340366A1 Use of urea adducts of fatty acids |
| 06/01/1995 | DE4339985A1 Pharmaceutical compsn. contg. di:halo-quinoline deriv. |
| 06/01/1995 | CA2177388A1 Design of drugs involving receptor-ligand-dna interactions |
| 06/01/1995 | CA2177037A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | CA2176715A1 Amphiphilic derivatives of guanidine |
| 06/01/1995 | CA2176714A1 Amphiphilic derivatives of piperazine |
| 06/01/1995 | CA2154680A1 In vivo free-radical generator |
| 05/31/1995 | EP0655251A1 Pharmaceutical composition for preventing or treating |
| 05/31/1995 | EP0655239A1 Liposomes encapsulating doxorubicine |
| 05/31/1995 | EP0655069A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
| 05/31/1995 | EP0654973A1 System of drug delivery to the lymphatic tissues |
| 05/31/1995 | EP0362339B1 Use of a support with immobilized molecules or substances thereon |
| 05/31/1995 | EP0329778B1 Molecular decoyants and methods of use thereof |
| 05/31/1995 | CN1103234A Taste modifying method and bitter taste reducing method |
| 05/31/1995 | CA2137025A1 Liquid preparations containing cyclosporin and process for preparing same |
| 05/30/1995 | US5420285 Protein labelling utilizing certain pyridyl hydrazines, hydrazides and derivatives |
| 05/30/1995 | US5420251 Anti-idiotype antibodies specific for the parotope of antibodies which bind to IgE-bearing B cells but not basophils |
| 05/30/1995 | US5420197 Wound and burn dressings, cosmetic applications, drug delivery |
| 05/30/1995 | US5420124 Stable, painless piroxicam potassium injectable composition |
| 05/30/1995 | US5420106 Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
| 05/30/1995 | US5420105 Polymeric carriers for non-covalent drug conjugation |
| 05/30/1995 | US5420026 Self-assembling replication defective hybrid virus particles |
| 05/30/1995 | US5419918 Method for the manufacture of a controlled release solid unit dosage form |
| 05/30/1995 | US5419917 Controlled release hydrogel formulation |
| 05/30/1995 | US5419916 Gelatin coating composition and hard gelatin capsule |
| 05/30/1995 | US5419914 Phospholipid analogue vesicle |
| 05/30/1995 | US5419912 Adhesive patch for percutaneous delivery of isosorbide dinitrate |
| 05/30/1995 | US5419898 Antiallergic composition for ophthalmic or nasal use |
| 05/30/1995 | US5419893 Aminopolycarboxylic acids and derivatives thereof for magnetic resonance imaging |
| 05/30/1995 | US5419892 Microfluidization of calcium/oxyanion-containing particles |
| 05/30/1995 | CA1335748C Crosslinked gelatins |
| 05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
| 05/26/1995 | WO1995014037A1 Transparent liquid for encapsulated drug delivery |
| 05/26/1995 | WO1995013832A1 Immobilized labelling method |
| 05/26/1995 | WO1995013831A1 Antibody to ocular and vaginal surface epithelium |
| 05/26/1995 | WO1995013830A1 Method for inhibiting angiogenesis using heparinase |
| 05/26/1995 | WO1995013814A1 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 05/26/1995 | WO1995013801A1 Fatty acid delivery system |
| 05/26/1995 | WO1995013799A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 05/26/1995 | WO1995013798A1 Controlled release preparation |
| 05/26/1995 | WO1995013796A1 Vesicles with controlled release of actives |
| 05/26/1995 | WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA) |
| 05/26/1995 | CA2176934A1 Method for inhibiting angiogenesis using heparinase |
| 05/26/1995 | CA2176933A1 Controlled release preparation |
| 05/26/1995 | CA2175557A1 Immobilized labelling method |
| 05/26/1995 | CA2109989A1 Polymerized collagen-based anti-fibroid composition |
| 05/24/1995 | EP0654484A2 Pharmaceutical compositions containing inclusion compounds of thioctic or dihydroliponic acid with cyclodextrins and in granule form or in chewable or effervescent tablet form |
| 05/24/1995 | EP0654268A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1 |
| 05/24/1995 | EP0654263A1 Sustained release composition and a method of preparing pharmaceutical compositions |
| 05/24/1995 | EP0654059A1 Copolymers of polyaspartic acid |
| 05/24/1995 | EP0654046A1 Auto-cross-linked gellan gum |
| 05/24/1995 | EP0654040A1 Pharmaceutical composition containing botulinum b complex |
| 05/24/1995 | EP0653990A1 Timing valve for the discontinuous metering of a volume flow. |
| 05/24/1995 | EP0653943A1 Targeting somatic gene therapy to joints |
| 05/24/1995 | EP0653938A1 Topical composition |
| 05/24/1995 | EP0653934A1 Method of preparing liposomes |
| 05/24/1995 | EP0653931A1 Industrial, pharmaceutical and cosmetic applications for cultured plant cell gums |
| 05/24/1995 | EP0630275A4 Fibrin sealant delivery method. |
| 05/24/1995 | EP0630238A4 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa). |
| 05/24/1995 | EP0553178B1 Biphasic release formulations for lipophilic drugs |
| 05/24/1995 | EP0500802B1 Liposomal compositions |
| 05/24/1995 | EP0460143B1 Rolipram-containing composition for transdermal application |
| 05/24/1995 | DE4339750A1 Treating skin disease such as acne |
| 05/24/1995 | CN1102757A Colloidally dispersible acive compound |
| 05/24/1995 | CN1028485C Compound xidi iodine sucked tablet and making method thereof |
| 05/23/1995 | US5418223 Method for lyophilization of cyclophosphamide and product |
| 05/23/1995 | US5418222 Multi-layered collagen film compositions for delivery of proteins and methods of using same |
| 05/23/1995 | US5417983 Drug release controlling material responsive to changes in temperature |
| 05/18/1995 | WO1995013312A1 Water soluble active sulfones of poly(ethylene glycol) |
| 05/18/1995 | WO1995013291A1 Neuron-glia cell adhesion molecule, ng-cam, in treatment of nerve damage |
| 05/18/1995 | WO1995013095A2 Therapy |
| 05/18/1995 | WO1995013090A1 Improved interferon polymer conjugates |
| 05/18/1995 | WO1995013065A1 Fenbendazole formulations |
| 05/18/1995 | WO1995013055A1 Sustained release formulations for 24 hour release of metoprolol |
| 05/18/1995 | WO1995013053A1 Taxol formulation |
| 05/18/1995 | WO1995013052A1 Propylene glycol stearate vesicles |
| 05/18/1995 | WO1995013051A1 Sucrose distearate lipid vesicles |